HKH

HARRIS KUO HAO HUANG

R&D Director

SHANXI ZHENDONG MEDPHARM CO.,LTD.

About me

Registration Type
ATT

Is member of

MPLA (Monophosphoryl Lipid A)
Exhibitors

is attending

Boosting DSCSA Regulatory Preparedness for FDA’s Drug Supply Chain Security Act Compliance with Copilot Integrated Generative AI/ML

Conference Theater 2

Difficulties Meeting US FDA Regulatory Requirements

Conference Theater 2
Purna Thakker · ADPT Solution

China Drug Master File (DMF) Comparing with U.S. and EU

Conference Theater 2

Using New Technologies to Improve Formulation of Poorly Soluble Drugs – Does It Matter?

Tuesday, May 7, 2024 7:50 PM to 7:55 PM
Conference Theater 2
Ole Wiborg · ZERION PHARMA, A/S

CrisBio®: A Novel, Natural and Scalable Protein Expression System

Tuesday, May 7, 2024 8:10 PM to 8:15 PM
Conference Theater 2

Log in

See all the content and easy-to-use features by logging in or registering!